CT03 - Stimulating Results for Diabetes-Related Neuropathy Pain Treatment with Nevro HFX
Sunday, August 14, 2022
8:45 AM – 9:15 AM ET
Location: Exhibit Hall - Education Theater A
Sponsored By
Join an informative discussion on the most effective, FDA-approved treatment for refractory pain from diabetes-related neuropathy. Nevro HFX is the only high-frequency (10 kHz), spinal cord stimulation (SCS) therapy and is the only treatment to demonstrate neurological (numbness, tingling, burning, cold) symptom improvements. See the latest clinical data out to 24-months; and hear firsthand the experience of a real Nevro patient. Join us to learn how this revolutionary treatment could improve the lives of patients suffering from diabetes-related neuropathy.